Alembic Pharmaceuticals Limited (APLLTD.NS)
INR 1045.0
(-1.06%)
INR 1045.0
(-1.06%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.86 Billion INR | -39.22% |
| 2022 | 35.1 Billion INR | 20.4% |
| 2021 | 29.16 Billion INR | 18.63% |
| 2020 | 24.58 Billion INR | 18.93% |
| 2019 | 20.66 Billion INR | 11.37% |
| 2018 | 18.55 Billion INR | 26.84% |
| 2017 | 14.63 Billion INR | 0.65% |
| 2016 | 14.53 Billion INR | 13.86% |
| 2015 | 12.76 Billion INR | 42.08% |
| 2014 | 8.98 Billion INR | 21.43% |
| 2013 | 7.39 Billion INR | 31.55% |
| 2012 | 5.62 Billion INR | -0.47% |
| 2011 | 5.65 Billion INR | 35.89% |
| 2010 | 4.15 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.51 Billion INR | 15.84% |
| 2023 Q2 | 9.92 Billion INR | 5.6% |
| 2023 Q1 | 9.4 Billion INR | 12.47% |
| 2023 FY | 21.33 Billion INR | -39.22% |
| 2023 Q3 | 9.72 Billion INR | -2.01% |
| 2023 Q4 | 4.75 Billion INR | -51.1% |
| 2022 Q1 | 9.36 Billion INR | 39.39% |
| 2022 Q3 | 8.71 Billion INR | 0.56% |
| 2022 Q4 | 8.35 Billion INR | -4.12% |
| 2022 FY | 35.1 Billion INR | 20.4% |
| 2022 Q2 | 8.66 Billion INR | -7.41% |
| 2021 Q1 | 7.58 Billion INR | 103.98% |
| 2021 Q2 | 7.56 Billion INR | -0.18% |
| 2021 Q3 | 7.29 Billion INR | -3.63% |
| 2021 Q4 | 6.71 Billion INR | -7.9% |
| 2021 FY | 29.16 Billion INR | 18.63% |
| 2020 FY | 24.58 Billion INR | 18.93% |
| 2020 Q2 | 7.45 Billion INR | 16.9% |
| 2020 Q4 | 3.71 Billion INR | -47.15% |
| 2020 Q1 | 6.37 Billion INR | 183.05% |
| 2020 Q3 | 7.03 Billion INR | -5.66% |
| 2019 Q2 | 6.58 Billion INR | 18.68% |
| 2019 Q3 | 6.27 Billion INR | -4.75% |
| 2019 Q4 | 2.25 Billion INR | -64.09% |
| 2019 FY | 20.66 Billion INR | 11.37% |
| 2019 Q1 | 5.55 Billion INR | 136.88% |
| 2018 Q1 | 4.83 Billion INR | 8.0% |
| 2018 Q2 | 5.81 Billion INR | 20.18% |
| 2018 Q4 | 2.34 Billion INR | -57.9% |
| 2018 Q3 | 5.56 Billion INR | -4.26% |
| 2018 FY | 18.55 Billion INR | 26.84% |
| 2017 Q3 | 4.52 Billion INR | 7.1% |
| 2017 FY | 14.63 Billion INR | 0.65% |
| 2017 Q4 | 4.47 Billion INR | -1.02% |
| 2017 Q2 | 4.22 Billion INR | 9.28% |
| 2017 Q1 | 3.86 Billion INR | -8.95% |
| 2016 FY | 14.53 Billion INR | 13.86% |
| 2016 Q1 | 3.99 Billion INR | 6.7% |
| 2016 Q2 | 4.75 Billion INR | 18.96% |
| 2016 Q3 | 4.41 Billion INR | -7.19% |
| 2016 Q4 | 4.24 Billion INR | -3.75% |
| 2015 Q4 | 3.74 Billion INR | 6.15% |
| 2015 Q3 | 3.52 Billion INR | -15.95% |
| 2015 Q2 | 4.19 Billion INR | 49.31% |
| 2015 Q1 | 2.81 Billion INR | 65.73% |
| 2015 FY | 12.76 Billion INR | 42.08% |
| 2014 Q3 | 2.41 Billion INR | -6.57% |
| 2014 Q2 | 2.58 Billion INR | 12.59% |
| 2014 Q1 | 2.29 Billion INR | 93.99% |
| 2014 FY | 8.98 Billion INR | 21.43% |
| 2014 Q4 | 1.69 Billion INR | -29.84% |
| 2013 FY | 7.39 Billion INR | 31.55% |
| 2013 Q4 | 1.18 Billion INR | -45.55% |
| 2013 Q1 | 1.91 Billion INR | 94.63% |
| 2013 Q3 | 2.17 Billion INR | 2.68% |
| 2013 Q2 | 2.11 Billion INR | 10.38% |
| 2012 Q4 | 986.43 Million INR | -37.26% |
| 2012 Q1 | 1.46 Billion INR | 0.0% |
| 2012 FY | 5.62 Billion INR | -0.47% |
| 2012 Q2 | 1.59 Billion INR | 9.05% |
| 2012 Q3 | 1.57 Billion INR | -1.71% |
| 2011 FY | 5.65 Billion INR | 35.89% |
| 2010 FY | 4.15 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -2636.688% |
| Ind-Swift Limited | 946.56 Million INR | -1576.553% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1510.573% |
| Sakar Healthcare Limited | 204.07 Million INR | -7676.253% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 71.487% |
| Innova Captab Limited | 931.03 Million INR | -1604.532% |
| Divi's Laboratories Limited | 14.17 Billion INR | -11.995% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -541.589% |
| Morepen Laboratories Limited | 1.98 Billion INR | -698.496% |
| Mankind Pharma Limited | 29.27 Billion INR | 45.787% |
| Sequent Scientific Limited | 2.9 Billion INR | -446.89% |
| Wanbury Limited | 978.96 Million INR | -1521.068% |
| Laurus Labs Limited | 11.9 Billion INR | -33.249% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1601.48% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -36.33% |
| Alembic Limited | 872.45 Million INR | -1718.964% |
| Hikal Limited | 4.46 Billion INR | -255.52% |
| Neuland Laboratories Limited | 2.92 Billion INR | -441.675% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -7.282% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 66.201% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -621.022% |
| Themis Medicare Limited | 1.12 Billion INR | -1309.64% |
| RPG Life Sciences Limited | 1.63 Billion INR | -870.327% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 87.326% |
| Lupin Limited | 125.09 Billion INR | 87.314% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -657.852% |
| Wockhardt Limited | 8.48 Billion INR | -87.143% |
| Vaishali Pharma Limited | 84.02 Million INR | -18785.98% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -416.189% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -3518.675% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -9.795% |
| FDC Limited | 3.49 Billion INR | -353.451% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 83.448% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -3747.881% |
| Eris Lifesciences Limited | 4.94 Billion INR | -221.058% |
| Venus Remedies Limited | 1.91 Billion INR | -728.15% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1466.514% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1018.197% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -27126.35% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -629.809% |
| Shilpa Medicare Limited | 3.33 Billion INR | -375.971% |
| Albert David Limited | 1.02 Billion INR | -1446.533% |
| Ajanta Pharma Limited | 30.46 Billion INR | 47.904% |
| Hester Biosciences Limited | 908.84 Million INR | -1646.149% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1031.296% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -521.342% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1237.422% |
| Windlas Biotech Limited | 1 Billion INR | -1476.706% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -429.802% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -111556.23% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -9682.343% |
| Granules India Limited | 10.31 Billion INR | -53.884% |
| Aarti Drugs Limited | 1.16 Billion INR | -1259.314% |
| Bal Pharma Limited | 555.62 Million INR | -2756.184% |
| Alkem Laboratories Limited | 32.83 Billion INR | 51.668% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 89.707% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1377.37% |
| Medicamen Biotech Limited | 335.16 Million INR | -4634.864% |
| Unichem Laboratories Limited | 6.72 Billion INR | -135.95% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -3383.368% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -232593.548% |
| Valiant Laboratories Limited | 138.02 Million INR | -11397.366% |
| Orchid Pharma Limited | 800.77 Million INR | -1881.803% |
| Medico Remedies Limited | 59.67 Million INR | -26493.548% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -647.096% |
| Ipca Laboratories Limited | 18.98 Billion INR | 16.421% |
| Brooks Laboratories Limited | 51.18 Million INR | -30907.62% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -4491.489% |
| Piramal Enterprises Limited | 63.65 Billion INR | 75.068% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 25.919% |
| NATCO Pharma Limited | 10.05 Billion INR | -57.782% |
| Suven Life Sciences Limited | 109.75 Million INR | -14359.863% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -34282.745% |
| Strides Pharma Science Limited | 9.16 Billion INR | -73.207% |
| Indoco Remedies Limited | 12.06 Billion INR | -31.576% |
| Alpa Laboratories Limited | 127.38 Million INR | -12358.549% |
| Lasa Supergenerics Limited | 291.17 Million INR | -5350.246% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -415.786% |